Visa stock could potentially reward long-term shareholders with market-beating capital gains and an attractive dividend yield on a cost basis. Read a full analysis here.
Pfizer's drug pipeline is still improving with several successful recent drug launches. Read why I think PFE stock presents as a core holding conviction buy.
UCO is a high-risk, double-long oil market exposure. The Fund attempts to track an index on a daily basis. See why I conclude oil futures prices are overvalued.